IP Library Assignment 041095/0554
Patent Assignment
Reel/Frame 041095/0554

Security Interest

Recorded: 2017-01-26 Pages: 9
Assignor
EAGLE PHARMACEUTICALS, INC.
Executed: 2017-01-26
Assignee
JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
10 SOUTH DEARBORN, CHICAGO, ILLINOIS, 60603
Covered Properties (27)
Alcohol Free Formulation of Argatroban
Application: 13/618,532 →
Publication: US 2013/0023559
Formulations of Bendamustine
Patent: 9,572,796 →
Application: 15/013,424 →
Publication: US 2016/0143887
Formulations of Bendamustine
Patent: 9,572,797 →
Application: 15/013,436 →
Publication: US 2016/0143888
Formulations of Bendamustine
Application: 13/767,672 →
Publication: US 2013/0210879
Formulations of Bendamustine
Patent: 9,597,397 →
Application: 14/857,064 →
Publication: US 2016/0000759
Formulations of Bendamustine
Patent: 9,597,398 →
Application: 15/008,819 →
Publication: US 2016/0144034
Formulations of Bendamustine
Patent: 9,597,399 →
Application: 15/008,827 →
Publication: US 2016/0144035
Formulations of Bendamustine
Patent: 9,572,887 →
Application: 15/184,464 →
Publication: US 2016/0296621
Formulations of Bendamustine
Patent: 9,572,888 →
Application: 15/184,488 →
Publication: US 2016/0296622
Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration
Patent: 9,579,384 →
Application: 14/820,291 →
Publication: US 2015/0343061
Aqueous Buffer-Free Bivalirudin Compositions
Application: 14/711,359 →
Publication: US 2015/0328317
Aqueous Buffer-Free Bivalirudin Compositions
Application: 14/982,813 →
Publication: US 2016/0106840
Fulvestrant Compositions and Methods of Their Use
Application: 62/420,555 →
Fulvestrant Formulations
Application: 62/332,842 →
Pemetrexed Formulations
Application: 15/048,416 →
Publication: US 2017/0239250
Pharmaceutical Compositions Containing Pemetrexed Having Extended Storage Stability
Patent: 9,655,898 →
Application: 13/806,624 →
Publication: US 2013/0231357
Alcohol Free Formulation of Argatroban
Patent: 7,589,106 →
Application: 11/904,067 →
Publication: US 2008/0076798
Alcohol Free Formulation of Argatroban
Patent: 7,687,516 →
Application: 11/973,485 →
Publication: US 2008/0300272
Formulations of Bendamustine
Patent: 8,609,707 →
Application: 13/016,473 →
Publication: US 2011/0184036
Formulations of Bendamustine
Patent: 9,265,831 →
Application: 14/031,879 →
Publication: US 2014/0024691
Formulations of Bendamustine
Patent: 9,034,908 →
Application: 13/838,090 →
Publication: US 2013/0253025
Formulations of Bendamustine
Patent: 9,144,568 →
Application: 14/714,578 →
Publication: US 2015/0250766
Method of Treating Bendamustine-Responsive Conditions in Patients Requiring Reduced Volumes for Administration
Patent: 9,000,021 →
Application: 13/838,267 →
Publication: US 2013/0253026
Ready-To-Use Bivalirudin Compositions
Patent: 7,803,762 →
Application: 12/545,036 →
Ready-To-Use Bivalirudin Compositions
Patent: 7,713,928 →
Application: 12/563,821 →
Formulations of Daptomycin
Patent: 8,431,539 →
Application: 12/884,653 →
Publication: US 2011/0172167
Vial with Collar Label
Patent: 676,572 →
Application: 29/403,209 →
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 26, 2007
From: PALEPU, NAGESWARA R.
To: SCIDOSE LLC
Reel/Frame 019937/0928 →
Assignment of Assignor's Interest Dec 14, 2007
From: SCIDOSE, LLC
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 020246/0476 →
Assignment of Assignor's Interest Dec 14, 2007
From: PALEPU, NAGESH R.
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 020246/0357 →
Assignment of Assignor's Interest Mar 9, 2011
From: PALEPU, NAGESH R.; BUXTON, PHILIP CHRISTOPHER
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 025923/0962 →
Assignment of Assignor's Interest Apr 24, 2014
From: PALEPU, NAGESH R.; BUXTON, PHILIP CHRISTOPHER; SUNDARAM, SRIKANTH
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 032751/0237 →
Assignment of Assignor's Interest Apr 30, 2014
From: PALEPU, NAGESH R.; BUXTON, PHILIP CHRISTOPHER
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 032790/0596 →
Assignment of Assignor's Interest May 20, 2015
From: EAGLE PHARMACEUTICALS, INC.
To: SCIDOSE, LLC
Reel/Frame 035682/0656 →
License May 22, 2015
From: EAGLE PHARMACEUTICALS, INC.
To: CEPHALON, INC.
Reel/Frame 035696/0856 →
Assignment of Assignor's Interest Sep 15, 2015
From: CHEN, FENG-JING; KRILL, STEVEN L.
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 036569/0069 →
Assignment of Assignor's Interest Dec 29, 2015
From: SCIDOSE, LLC
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 037378/0274 →
Assignment of Assignor's Interest May 18, 2016
From: CHEN, FENG-JING; KRILL, STEVEN L.
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 038635/0065 →
Assignment of Assignor's Interest Dec 28, 2017
From: CHEN, FENG-JING; KRILL, STEVEN L.
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 044499/0001 →
Assignment of Assignor's Interest Oct 19, 2022
From: PALEPU, NAGESH R.; BUXTON, PHILIP CHRISTOPHER
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 061473/0077 →
Release of Security Interest Apr 1, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: EAGLE PHARMACEUTICALS, INC.
Reel/Frame 070703/0524 →
Security Interest May 14, 2025
From: EAGLE SUBI LLC, A DELAWARE CORPORATION
To: LSI FINANCING LLC
Reel/Frame 071275/0866 →
Grant of Security Interest Feb 18, 2026
From: EAGLE PHARMACEUTICALS, INC
To: ANKURA TRUST COMPANY, LLC.
Reel/Frame 074849/0457 →